REVIEW
On the benefit of standard vaccines: tetanus
NEW ON THE MARKET
Idarucizumab (PRAXBIND): antidote for dabigatran
a-t READER'S QUESTIONS AND COMMENTS
Red yeast rice: withdrawal of products from the market is overdue
Is it allowed to substitute immediate-release preparations for prolonged-release preparations?
IN BRIEF
Rivaroxaban (XARELTO) rehabilitated?
Betahistine (e.g. VASOMOTAL) for MENIÈRE´s disease
Fusafungine (LOCABIOSOL): withdrawal from the market recommended
Misleading trade names of painkillers
Error analysis: BIA 10-2474 in phase 1 testing
CURRENT ADR NETWORK REPORT
Urinary incontinence due to safinamide (XADAGO)? free article
SIDE EFFECTS
e a-t IN THE INTERNET
Dimethyl fumarate (TECFIDERA): first progressive multifocal leukoencephalopathy with only moderate lymphopenia